Brazil launches largest Real-World study on medical cannabis
NCT ID NCT07362407
First seen Jan 25, 2026 · Last updated May 19, 2026 · Updated 17 times
Summary
This study follows 384 adults in Brazil who are using cannabis-based products prescribed by their doctors for chronic pain, anxiety, or depression. Researchers will not provide the medication but will track patients for 6 months through online surveys to measure changes in quality of life, symptoms, and side effects. The goal is to gather real-world evidence to help doctors and health authorities make safer, more informed decisions about cannabinoid treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Universidade Federal de Santa Catarina (UFSC), Centro de Ciências Biológicas (CCB), Campus Universitário, Trindade, Florianópolis - SC.
Florianópolis, Santa Catarina, 88049-900, Brazil
Conditions
Explore the condition pages connected to this study.